35 Therapies in Phase 2 and 3 Clinical Trials Raise Hopes in Alzheimer’s Community

35 Therapies in Phase 2 and 3 Clinical Trials Raise Hopes in Alzheimer’s Community
Alzheimer's research is gaining momentum, with 27 Phase 3 and eight Phase 2 clinical trials either in progress or expected over the next five years. The good news surfaced in a revised pipeline analysis of Alzheimer’s therapies that researchers presented at the Alzheimer's Association International Conference in London. The event, which started July 16, runs through July 20. Alzheimer's patients, families, doctors and caregivers have been waiting a long time for some encouragement. It's been 14 years since U.S. and European regulators approved a new t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *